当前位置: 首页 > 详情页

Long-term survival of heterotopic heart transplants in allogenic rats without using anti-rejection drugs after inducing immune tolerance.

| 导出 |

文献详情

资源类型:

收录情况: ◇ 中华系列

机构: [1]Xuan Wu Hospital, Capital University of Medical Sciences, Beijing.
出处:
ISSN:

摘要:
Graft rejection is a baffling problem in organ transplantation which has so far no successful resolution. Present antirejection therapy is expensive, toxic, susceptible to infection, oncogenesis and atherosclerosis. With the use of 2 extremely histoincompatible strains of rats as model, it was found that when six donor splenocytes preconditioned by an extract from the culture medium of streptomyces caespitosus were injected into the host, after 2 weeks immune tolerance heterotopic transplanted donor hearts could survive normally more than 100 days without using any anti-rejection drug. Their mean survival time was 141.4 +/- 2.56 days, while that in the control group was only 11.7 +/- 3.48 days (P < 0.005). Thus, the present research offers some bright prospects in the area of organ transplantation.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[1994]版:
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科
第一作者:
第一作者机构: [1]Xuan Wu Hospital, Capital University of Medical Sciences, Beijing.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16399 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院